1. Home
  2. VTMX vs RDY Comparison

VTMX vs RDY Comparison

Compare VTMX & RDY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VTMX
  • RDY
  • Stock Information
  • Founded
  • VTMX 1998
  • RDY 1984
  • Country
  • VTMX Mexico
  • RDY India
  • Employees
  • VTMX N/A
  • RDY N/A
  • Industry
  • VTMX
  • RDY Biotechnology: Pharmaceutical Preparations
  • Sector
  • VTMX
  • RDY Health Care
  • Exchange
  • VTMX Nasdaq
  • RDY Nasdaq
  • Market Cap
  • VTMX 2.3B
  • RDY 2.1B
  • IPO Year
  • VTMX 2023
  • RDY N/A
  • Fundamental
  • Price
  • VTMX $25.84
  • RDY $14.49
  • Analyst Decision
  • VTMX Sell
  • RDY Strong Buy
  • Analyst Count
  • VTMX 2
  • RDY 2
  • Target Price
  • VTMX $29.00
  • RDY $16.95
  • AVG Volume (30 Days)
  • VTMX 179.5K
  • RDY 1.4M
  • Earning Date
  • VTMX 07-24-2025
  • RDY 07-28-2025
  • Dividend Yield
  • VTMX 2.54%
  • RDY 0.56%
  • EPS Growth
  • VTMX N/A
  • RDY 1.47
  • EPS
  • VTMX 0.13
  • RDY 0.79
  • Revenue
  • VTMX $258,927,122.00
  • RDY $3,809,801,863.00
  • Revenue This Year
  • VTMX $17.35
  • RDY $10.24
  • Revenue Next Year
  • VTMX $11.82
  • RDY N/A
  • P/E Ratio
  • VTMX $19.19
  • RDY $18.37
  • Revenue Growth
  • VTMX 15.06
  • RDY 16.61
  • 52 Week Low
  • VTMX $21.30
  • RDY $12.26
  • 52 Week High
  • VTMX $31.41
  • RDY $16.89
  • Technical
  • Relative Strength Index (RSI)
  • VTMX 37.46
  • RDY 43.00
  • Support Level
  • VTMX $24.99
  • RDY $14.51
  • Resistance Level
  • VTMX $26.26
  • RDY $14.70
  • Average True Range (ATR)
  • VTMX 0.52
  • RDY 0.16
  • MACD
  • VTMX -0.10
  • RDY -0.06
  • Stochastic Oscillator
  • VTMX 31.39
  • RDY 23.42

About VTMX Corporacion Inmobiliaria Vesta S.A.B de C.V. each representing ten (10)

Corporacion Inmobiliaria Vesta SAB de CV is an internally managed real estate company that owns, manages, develops, and leases industrial properties in Mexico. The Company's primary business is the acquisition, development, and management of industrial and distribution center real estate. The company designs and constructs park-to-suit projects across various industries; undertakes build-to-suit projects; and provides site selection, design and engineering, and sale and leaseback services. The primary source of revenue is the rental income received from customers under operating leases. It serves aerospace, automotive, food and beverage, logistics, medical devices, plastics, and other industries.

About RDY Dr. Reddy's Laboratories Ltd

Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

Share on Social Networks: